Navigation Links
Remedi SeniorCare Expands Distribution of the Paxit™ Med-Pass Solution, the New Standard in Medication Administration
Date:3/10/2011

BALTIMORE, March 10, 2011 /PRNewswire/ -- Remedi SeniorCare®, which is among the nation's largest independent institutional pharmacies, is revolutionizing the long-term care (LTC) pharmacy industry with the Paxit™ med-pass system, its 24-hour unit dose medication administration system enabled by fully automated centralized proprietary dispensing technology. Remedi is continuing to expand its existing operations in Maryland and the Washington, D.C. area, where its robotic systems have industrialized medication administration, transforming the way personnel in skilled care facilities manage and deliver medications to their residents. The company is planning further deployment of the innovative Paxit systems in Virginia, Michigan and Ohio later in 2011.

Paxit delivers a 24-hour unit-dose cycle of individually blistered medications in compliance packaging, making it the industry's most accurate medication administration system, dramatically reducing errors and medication waste while increasing nurse efficiency up to 30 percent. In addition, Paxit users can save 7 to 15 percent on overall medication costs, significantly improving the operating efficiencies within the LTC market. Since its launch in August 2009, Paxit has dispensed more than 12 million doses in 4 million Paxit bags. Currently, the system services more than 5,000 residents in Maryland, Delaware, DC and Northern Virginia.

"The long-term care pharmacy industry has been devoid of significant innovation for decades," said Michael Bronfein, CEO of Remedi SeniorCare. "As part of Remedi's commitment to enabling its customers' success, we have made the significant investment to develop this groundbreaking system, which we believe defines the new standard in medication accuracy, unparalleled patient safety and cost savings. Paxit is an industry game-changer and the answer to improving nursing satisfaction and efficiency and reducing medication costs throughout the entire system."

The patent-pending Paxit technology is the result of more than five years and millions of dollars in research and development that enables its customers to achieve the benefits sought in the Patient Protection and Affordable Care Act.  Benefits sought include 7-day or shorter fills for prescriptions, commonly referred to as "short-cycle dispensing," ultimately leading to reduced waste associated with typical 30-day fills.   Without the need for additional government regulation, Paxit exceeds the requirement of the Act by providing automated daily dose dispensing, eliminating the waste associated with many LTC facilities.  

Saves Nurses Time.  By using Paxit, nurses on average reduce their medication administration time by 25 to 30 percent with greater accuracy and improved care. Nurses save hours a month on administrative work by eliminating the time associated with returns and refill processing.

  • Increases accuracy. Dispensed by patent-pending advanced automation technology, medications are checked multiple times and are traceable to the pill level. Because Paxit reduces variability, nurses enjoy a far easier and safer medication administration system.
  • Significantly Reduces Medication Costs. Paxit reduces the amount of on-hand drug inventory from 30 days to 2 days. It provides more flexibility as residents' medications change, and enables environmentally responsible business practices by dramatically reducing medication waste in long-term care. Paxit can save users 7 to 15 percent per month on their drug costs depending on resident acuity.

Nurse involvement at every stage of development of Paxit resulted in a user-friendly design and smooth process flow:

  • Easy tear-open bags and pop-out blisters with rounded corners to protect fingers;
  • Easy-to-read bags with large print for identifying the most important information; alphabetical order of medications in the same order as the Medication Administration Record (MAR); complete administration information including date, time, room and both brand and generic drug names;
  • HIPAA compliance with ability to separate resident name from medication information on the bag.

Paxit is the first and only medication administration system designed by nurses with resident safety, nursing efficiency and cost reduction as their primary objectives.

About Remedi SeniorCare

Remedi SeniorCare, a leading long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently serving eight states and more than 22,000 residents, Remedi SeniorCare helps long-term care facilities achieve outstanding care, medication safety, operational efficiencies and Healthier Results™. For more information, please visit www.RemediRX.com.

About Sterling Partners

Sterling Partners, the lead investor in Remedi SeniorCare, is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.SterlingPartners.com.


'/>"/>
SOURCE Remedi SeniorCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
2. Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities
3. Generational Equity Announces Sale of B-Pharm, Inc. dba Remedies Pharmacy to a Private Investment Group
4. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status
5. Native Remedies NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious Emerson EQP Seal
6. Bionorica Offers Tips on Selecting Safe and Effective Natural Remedies for Children
7. Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam
8. When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research
9. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
10. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
11. QPS Expands Clinical Trial Services with Acquisition of Qualitix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
(Date:2/16/2017)... -- Prescription pain medications provided by "physicians in the months ... opioid use to take hold," according to a new ... The New England Journal of Medicine (NEJM). ... acute pain than in almost any other medical setting," ... the American College of Emergency Physicians. "The challenge is ...
(Date:2/16/2017)... Research and Markets has announced the addition of the "Global ... Cancer Type, Technology - Forecast to 2025" report to their ... The ... a CAGR of around 28.6% over the next decade to reach ... the prominent trends that the market is witnessing include increasing demand ...
Breaking Medicine Technology:
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... Nashville, TN (PRWEB) , ... February 17, 2017 ... ... Services, Inc. (ISTS) brings its educational assistance management solution to the exhibit floor ... Convention Center in Orlando, Fla. , From Feb. 19–23, 2017, more than ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today announced that ... Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will be the ... patient signatures solution in healthcare . , Since it first introduced Electronic ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow ... Tri-Conference February 20 – 22 in San Francisco. As part of the Tri-Conference ... molecular pathology workflow solution, as well as its new precision medicine platform, “Crosswalk ...
(Date:2/16/2017)... New York, New York (PRWEB) , ... February ... ... hard work and determination. After what took over 10 years of research, development ... disruptive technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ...
Breaking Medicine News(10 mins):